A recent study led by Osaka University immunochemistry professor Hisashi Arase implicates the potential need to develop new COVID-19 vaccines to combat the evolving SARS-CoV-2…
Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. Dr. Ron Brown – Opinion Editorial…
Thanks to a valued community member, TrialSite shares recent study results led by Spanish researchers. With important results published in Frontiers in Cellular and Infection Microbiology,…
An interesting, some might suggest provocative, study emerged recently on the preprint server medRxiv that offers possibly some promising news. Of course, not peer-reviewed hence…
Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, announced today that Carragelose inactivates the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
